Tower Semiconductor
This is the archived full research. Read the story
Tower Semiconductor makes other companies' analog chips, and has become a leading maker of the light-carrying chips that link AI servers.
The scores
Growth3/4 ↑
Revenue rose 33% in the third quarter and is guided to $2.0B for 2026, but it fell 15% in 2023.
Business quality3/4 ↑
Customers prepaid to reserve its photonics capacity and it ramped first, but GlobalFoundries sells the same chips with US aid behind it.
Financial position4/4 →
About $1.32B of net cash at September 2026, and the expansion is funded from operations and prepayments.
Execution record3/4 ↑
Eight straight beats and capacity ahead of schedule, but the Intel sale and capacity corridor both fell through.
Per share capture3/4 →
Shares rise under 1% a year from stock pay and there are no buybacks; the chief executive sold heavily this summer.
Potential3/4 ↑
Yole sees silicon photonic chips growing 31% a year to 2030, and near-package optics could widen what Tower sells.
Risk profile2/4 →
Its main fab is in Israel, the photonics customers are few and unnamed, the cycle has turned before, and a rival is suing.
Valuation3/4 ↑
About 77% of a three-stage value near $173, just inside the margin of safety, yet 38.7 times trailing operating profit: fair, not deep.
Evidence quality3/4 →
Audited statements and filed advances, but the photonics split, the 2029 contracts and the market share are management's word.
The Verdict
We rate Tower Semiconductor Attractive. It is a solid business: customers design their light-carrying chips on its processes and have paid in advance to reserve its factories through 2028, and it has more cash than debt. The price is about 77% of our value of about $173 a share, just inside our 20% margin of safety, because the shares more than halved since June while sales kept rising. That value needs operating profit near 30 cents of each sales dollar, above any full year it has filed. Against us, GlobalFoundries is spending US aid on the same kind of chip, and the cushion is thin.
The long caseAI data centres need more optical links, silicon photonics replaces assembled parts, and Tower's prepaid capacity makes most of those chips.
How we weighed it
The price against our value
In its favour
Price at 77% of our value
The price sits just under the line where the margin of safety starts, a thin cushion with the bear case far below.
The business
In its favour
Solid
Customers prepaid to reserve its photonics capacity for years, and it was first to make these chips at volume.
Growth against what the price assumes
In its favour
Sales grow fast on capacity already bought and contracted, and the price asks for less growth than analysts expect.
What could go wrong
Against it
Its main fab is in Israel, the cycle has turned before, a few unnamed customers carry the photonics line, and the boss sold shares.
Against competitors
Cuts both ways
GlobalFoundries is pouring government money into the same chips and is suing over patents.
How its group is behaving
Cuts both ways
AI optics names fell together on fears the spending boom is peaking; the fall was the rating, not the sales.
The latest news and report
In its favour
The latest report was a record with a higher guide, and the shares fell anyway.
The evidence under this - 6 claims
- On a 23.7% normal margin and half the growth the value is about $63.12 (bear case), half the price.
- Three analysts forecast 2028; the path past 2027 is thin (C29).
$341.0M of the cash netted is customer advances owed back in wafers (C11), so the true net cash is smaller.
- Management concedes 'a little bit of competition' and says new entrants discount (C17).
- GlobalFoundries has $955M of aid to grow the same line (C18).
- The 2029 extension is management's word, partly 'contracts in advanced stages of negotiation' rather than signed (S03).
- The release warns that prepayments may have to be repaid if Tower cannot deliver the committed capacity (S02).
- Only about 65% of the new tools had begun depreciating in the third quarter, the CFO said, so costs rise as the rest come in (S03).
- Revenue fell 15.2% in 2023 and the margin halved in 2024 (C15).
The company
Many chip companies design chips but own no factory. Tower is one of the factories they hire. It specialises in analog chips, which handle radio signals, power and light rather than computing, and most of all now silicon photonics for data-centre links.
It runs fabs in Israel, in Newport Beach and San Antonio in the US, and in Japan. Silicon photonics puts the optical parts of a data link onto one silicon chip, made with ordinary chipmaking tools.
The evidence under this - 2 claims
How it makes money
Tower is paid per finished wafer, and more for harder processes. In 2025 sales were $1,566M and it kept about 12 cents of each sales dollar as operating profit, with its fabs partly empty.
Most of a fab's costs are fixed, so each extra wafer adds far more profit than the average one, and the margin rises fast as photonics fills the fabs. New tools are the big cost: 28% of sales in 2025.
The evidence under this - 4 claims
The figure is management's; no filing splits revenue by technology, and Tower reports one segment (S01).
Where the money comes from, stream by stream
| Stream | Share of sales (Q3 2026) | How it earns it |
|---|---|---|
| Silicon photonics wafers for optical transceivers | 45.6% | Light-carrying chips for the pluggable optical links between AI servers and switches, made to transceiver makers' designs. |
| SiGe, RF, power, image sensor and other analog wafers | 54.4% | Signal-driver chips for the same optical links, radio switches for phones, power chips, camera sensors and mixed-signal parts. |
Who runs it
Russell Ellwanger has been chief executive since 2005, after years at Applied Materials, and Oren Shirazi finance chief since 2004. Directors and managers own 0.5% of the shares. Most of the chief executive's share award pays on profit. Between July and September 2026 he sold shares many times at $215 to $250, none under a pre-set plan, and no insider bought.
The evidence under this - 3 claims
Why it wins, and who could beat it
Why customers come back
A customer designs its optical chip on Tower's process and then spends months proving it works in Tower's fabs, so moving it to another factory means redesigning and re-proving it. Customers have gone further and prepaid to reserve years of Tower's capacity, money they get back only as later purchases.
Tower says it was first to make these chips at high yields on both wafer sizes. The research firm Yole expects the market for silicon photonic chips to grow about 31% a year to 2030.
The evidence under this - 4 claims
- Management concedes 'a little bit of competition' and says new entrants discount (C17).
- GlobalFoundries has $955M of aid to grow the same line (C18).
- The 2029 extension is management's word, partly 'contracts in advanced stages of negotiation' rather than signed (S03).
- The release warns that prepayments may have to be repaid if Tower cannot deliver the committed capacity (S02).
GlobalFoundries is putting $955M of US aid into the same technology (C18).
Tower alone targets a $1.1B run rate in the fourth quarter of 2026 (C09), so the measure either counts differently or lags the market.
The threat
GlobalFoundries, a larger contract chipmaker, is moving $955M of its US government chip aid into silicon photonics, and calls optical networking a growth driver. It also filed patent suits against Tower in March 2026. TSMC, the largest chipmaker, offers photonics too. Specialty rivals such as X-Fab, Vanguard and Hua Hong compete for Tower's older lines.
The evidence under this - 5 claims
The rivals: GFS, TSM, UMC.
Who else does this, rival by rival
| Ticker | Rival | Where it competes | How far along | Priced against it |
|---|---|---|---|---|
| GFS | GlobalFoundries silicon photonics and SiGePriced against it: Yes | Silicon photonics and SiGe for optical data links | On sale | Yes |
| TSM | TSMC's photonics and packaging for co-packaged opticsPriced against it: One segment only | Silicon photonics and SiGe for optical data links | Announced | One segment only |
| GFS | GlobalFoundries RF, plus Vanguard, DB HiTek, X-Fab and Hua HongPriced against it: Yes | Other analog foundry: RF, power, image sensors and mixed-signal | On sale | Yes |
| UMC | United MicroelectronicsPriced against it: Yes | - | On sale | Yes |
How big it could get
How big this could get
Yole puts the silicon photonic chip market at $404M in 2024, rising to more than $2.1B in 2030.
That count is too small to size Tower's market: Tower's own photonics sales are already running at about half of Yole's 2030 figure. Nobody publishes a measure that fits, so the size of the prize is not established.
The evidence under this - 3 claims
Tower alone targets a $1.1B run rate in the fourth quarter of 2026 (C09), so the measure either counts differently or lags the market.
Yole may count die value at a different point in the chain than Tower's wafer revenue, so the two need not be comparable (C20).
The figure is management's; no filing splits revenue by technology, and Tower reports one segment (S01).
The results
The numbers
Sales grew 9.1% in the year to Dec 2025, faster than the 0.9% in the year before.
Operating margin is 12%, down from 19% in the year to Dec 2022.
Running costs take 11¢ of each sales dollar, about where it was (11¢) in the year to Dec 2021.
Each dollar put into the business earns 6.0% a year after tax, about where it was (9.2%) in the year to Dec 2021.
It used $48.9M of cash in the latest year, so the $1.15B it holds lasts about 23.5 years at that pace.
It holds $1.15B of cash against $162M of debt, $990M more cash than it owes.
The share count rose 3.5% in 4.0 years, and pay in shares costs 2.4% of sales.
All the numbers
Filed figures from the company's 10-K and 10-Q, read 2026-11-17. Fiscal years end in December.
| Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 | |
|---|---|---|---|---|---|
| Size and growth | |||||
| Sales | $1.51B | $1.68B | $1.42B | $1.44B | $1.57B |
| Sales growth | +19% | +11% | −15% | +0.9% | +9.1% |
| Profit | |||||
| Gross margin | 22% | 28% | 25% | 24% | 23% |
| Operating margin | 11% | 19% | 38% | 13% | 12% |
| Net margin | 9.9% | 16% | 36% | 14% | 14% |
| What growth costs, per sales dollar | |||||
| Research and development | 5.7% | 5.0% | 5.6% | 5.5% | 5.5% |
| Selling, general and admin | 5.1% | 4.8% | 5.1% | 5.2% | 5.3% |
| Pay in shares | 1.7% | 1.4% | 2.0% | 2.4% | 2.4% |
| Capital spending | 21% | 22% | 31% | 30% | 28% |
| Cash | |||||
| Cash from operations | $421M | $530M | $677M | $449M | $395M |
| Free cash flow | $107M | $163M | $232M | $12.5M | −$48.9M |
| Balance sheet | |||||
| Cash and short-term investments | $575M | $836M | $1.05B | $1.22B | $1.15B |
| Debt | $231M | $272M | $232M | $181M | $162M |
| Net cash | $344M | $564M | $820M | $1.04B | $990M |
| Returns and shares | |||||
| Return on capital | 9.2% | 14% | 20% | 6.6% | 6.0% |
| Shares (diluted) | 110M | 111M | 111M | 112M | 114M |
What growth costs
Growth has made Tower more profitable: research and overheads grew more slowly than sales, so operating profit rose from 10 cents per sales dollar in the first half of 2025 to 24 cents in the third quarter of 2026. What grows with sales is factories: plant spending rose from 21% of sales in 2021 to 28% in 2025.
The evidence under this - 3 claims
The last report (2 Nov)
In the three months to September 2026, sales rose 33% on a year earlier to $526.2M and 14% on the quarter before. Operating profit reached 24.2% of sales, against 12.8% a year earlier, as fuller fabs spread their fixed costs. Photonics brought in about $240M.
Management guided about $600M for the December quarter, which would make 2026 sales about $2.0B, and said it expects no dip in early 2027. The shares fell over the following days anyway.
What it did to the thesisIt showed the photonics ramp real and the margin rising as the fabs fill, the thing our value most needs. It did not show the margin reaching about 30 cents per sales dollar, which only the next quarters can.
The quarter in detail
Earnings per share $1.15 against $1.07 expected.
The evidence under this - 5 claims
The 20-F warns that a limited order backlog makes results hard to forecast quarter to quarter (S01).
The figure is management's; no filing splits revenue by technology, and Tower reports one segment (S01).
What management did with the money
Tower puts its cash into new tools rather than paying it out: no dividend and no buybacks. In the nine months to September 2026 it spent $534M on plant, mostly for photonics, while operations brought in $872M, helped by customers' prepayments. It is spending about $920M to roughly triple photonics capacity by late 2027.
Insiders in 2026Q3: 10 purchases and 37 sales, from their Form 4 filings.
The evidence under this - 4 claims
The 20-F lists delays in equipment delivery and installation, including vendors unable to travel to Israel, among the risks to the $920M plan (S01).
The price, and where we disagree
In short. Fair, and just cheap enough. The price is about three-quarters of what the business is worth if the margin reaches about 30 cents, at an 8% yearly return.
The shares closed at $133.42 on 16 November, down from $319.94 in June, while sales per share rose. They fell more than a fifth in a week twice, in July and again after the record quarter, on fears that rivals and an AI spending pause end the boom. Analysts are more positive than in March, and short selling has risen.
The next test is the December quarter's results, due around 10 February 2027.
The evidence under this - 4 claims
The 20-F warns that a limited order backlog makes results hard to forecast quarter to quarter (S01).
How we value it
- Method
- Cash the business will produce, in three stages
- Required return
- 8%
- Long-run growth
- 4%
- Moat
- An average moat
| Bear | Base | Bull | |
|---|---|---|---|
| Sales growth, years 1 to 3 | 13.9%, 19.9%, 16.6% | 27.8%, 39.8%, 33.2% | 34.8%, 49.8%, 41.5% |
| Normal operating margin | 23.7% | 29.6% | 32.6% |
| Return on new capital after year ten | 8% | 12% | 15% |
| Value a share | $63.12 | $173 | $283 |
- Price
- $133
- Priced on
- 16 Nov
- Price as a share of the base value
- 77%
- Starting growth the price pays for
- 37.7%
- Yearly return the price offers on the base case
- 8.9%
- Risk check: valued at 10%, the rate for a cyclical or indebted business
- $104
Where each figure comes from
| Figure | Source | Where exactly |
|---|---|---|
| Sales, the last full year | Filed report | Interim report (6-K) for the period to 31 Dec 2025, filed 2 Mar 2026; the full year. |
| Operating margin today | Filed report | Interim report (6-K) for the period to 31 Dec 2025, filed 2 Mar 2026; the full year. |
| Tax rate | Filed report | Interim report (6-K) for the period to 31 Dec 2025, filed 2 Mar 2026; the full year. |
| Sales per dollar of new capital | Filed report | Interim report (6-K) for the period to 31 Dec 2025, filed 2 Mar 2026: the year's sales over its operating capital. |
| Shares | Filed report | Interim report (6-K) for the period to 31 Dec 2025, filed 2 Mar 2026; the diluted share count. |
| Cash and investments | Filed report | Interim report (6-K) for the period to 31 Dec 2025, filed 2 Mar 2026; the balance sheet on that date. |
| Debt | Filed report | Interim report (6-K) for the period to 31 Dec 2025, filed 2 Mar 2026; the balance sheet on that date. |
| Sales growth, years 1 to 3 | Analysts' forecasts | FMP's consensus for the years to 31 Dec 2026, 31 Dec 2027 and 31 Dec 2028, as it stood when the value was struck on 17 Nov 2026: the average of 6 to 8 analysts' revenue estimates, 27.8%, 39.8%, 33.2%. FMP publishes how many analysts, not who they are. |
| Normal operating margin | Analysts' forecasts | FMP's consensus operating margin for the year to 31 Dec 2028, as it stood when the value was struck on 17 Nov 2026, the average of 6 analysts' estimates, 34.7%, less stock pay of 2.4% of sales and less the 2.7% the analysts add back on their adjusted basis. FMP publishes how many analysts, not who they are. |
| Return on new capital after year ten | Our method's rule | Set by our reading of the moat: the 8% rate with none, 12% with an average one, 15% with a strong one; the bear case earns the rate. |
| The bear and bull cases | Our method's rule | Our method's spread: the bear case takes half the growth and a fifth off the margin, the bull a quarter more growth and a tenth more margin. |
| Price | Market price | FMP's closing price on 16 Nov 2026. |
What each case rests on
Bear caseGrowth runs at half the analysts' path, 13.9%, 19.9% and 16.6%, as the AI optics boom pauses or a rival takes share, the margin settles a fifth lower at 23.7%, and new capital earns only the 8% rate: the downturn test.
Base caseRevenue follows the analysts' path (C29), 27.8%, 39.8% and 33.2%, matching the $2.0B guided for 2026 and management's capacity plan, then fades toward 4%, closing 30% of the gap each year; the margin rises from 12.4% to 29.6%, the analysts' 2028 figure less 2.4% stock pay and a 2.7-point basis gap (C35); tax is 15% under Pillar Two (C24); new capital earns 12%.
Bull caseGrowth runs a quarter above the analysts' path, 34.8%, 49.8% and 41.5%, as near-package optics and Track-1 add to the pluggable ramp, the margin reaches 32.6%, still below management's 38% model, and new capital earns 15%.
What moves the base value
| Lower | Higher | |
|---|---|---|
| Growth in years 1 to 3, a quarter lower or higher | $132 | $227 |
| The normal margin, 15% lower or higher | $144 | $203 |
| Capital per dollar of growth, a quarter more or less | $160 | $181 |
| Return on new capital after year ten, at the rate or one step up | $127 | $192 |
| The rate, a point higher or lower | $131 | $245 |
| Long-run growth a point lower | $153 | - |
Value a share as growth and margin change
| Normal margin ↓ · growth → | 50% | 75% | 100% | 125% | 150% |
|---|---|---|---|---|---|
| 23.7% | $80.42 | $103 | $134 | $173 | $224 |
| 26.6% | $90.83 | $118 | $154 | $200 | $260 |
| 29.6% | $101 | $132 | $173 | $227 | $296 |
| 32.6% | $112 | $147 | $193 | $254 | $332 |
| 35.5% | $122 | $161 | $213 | $281 | $368 |
Growth is shown as a share of the base case's. Green: the price is at or under 80% of that value. Red: at or over 120%.
How we read the multiple
Buyers pay about $13.6B for the business, net of spare cash. Its margin is rising fast: 12 cents per sales dollar in 2025, 24 cents by late 2026.
With sales on analysts' forecasts slowing toward 4% a year, the margin rising to about 30 cents, and an 8% yearly return:
- Normal-year operating profit is about $545M on today's sales.
- The business costs about 25 times that profit.
- That makes the shares worth about $173 each.
- At $133.42 they cost about 77% of that value, just inside our 20% margin.
Against its own history. Buyers pay about half what they paid in June for each dollar of its sales, though sales are growing faster now.
The evidence under this - 5 claims
$341.0M of the cash netted is customer advances owed back in wafers (C11), so the true net cash is smaller.
- On a 23.7% normal margin and half the growth the value is about $63.12 (bear case), half the price.
- Three analysts forecast 2028; the path past 2027 is thin (C29).
- Only about 65% of the new tools had begun depreciating in the third quarter, the CFO said, so costs rise as the rest come in (S03).
- Revenue fell 15.2% in 2023 and the margin halved in 2024 (C15).
$341.0M of that cash came in as customer advances, which are liabilities to be worked off in wafers (C11).
Priced against its rivals
The competitors its own annual report names, each confirmed against the rival's filing. Measured on price for each $1 of net worth, cheapest first:
| Ticker | Company | price for each $1 of net worth |
|---|---|---|
| GFS | GLOBALFOUNDRIES | 1.8× |
| UMC | United Microelectronics | 2.4× |
| TSEM | Tower Semiconductor | 4.6× |
The middle of the other 2 is 2.1. Tower Semiconductor Ltd. is dearest of 3.
Rivals' figures come from a data provider, so read the spread of the group rather than any single pair.
Against its two listed rivals only the price of what each owns minus what it owes compares cleanly, and on that Tower costs more than both.
Where we disagree with the market
An AI optics winner whose boom may peak soon, with a better-funded rival arriving, so worth selling on any wobble.
The capacity is prepaid through 2028 and the margin is rising as the fabs fill; at the price, the next two years are underpriced.
Analysts are nearly all positive, yet the shares have more than halved: the market is pricing how long the AI optics boom lasts and whether GlobalFoundries takes share. We think the prepaid capacity makes the next two years more certain than the price assumes.
Against us: our value needs a margin above any year Tower has filed, and management's own target is the main witness for it.
What analysts say, and the evidence
The evidence under this - 6 claims
- The 2029 extension is management's word, partly 'contracts in advanced stages of negotiation' rather than signed (S03).
- The release warns that prepayments may have to be repaid if Tower cannot deliver the committed capacity (S02).
- Only about 65% of the new tools had begun depreciating in the third quarter, the CFO said, so costs rise as the rest come in (S03).
- Revenue fell 15.2% in 2023 and the margin halved in 2024 (C15).
No full year Tower has filed reached an operating margin above 18.6% without the Intel termination fee (C15).
What could go wrong, and how we would know
The risks
- A funded rival GlobalFoundries is putting $955M of US aid into the same chips and could win Tower's customers' next designs.
- Patent suits GlobalFoundries is suing at the US trade commission, which can bar imports of wafers it finds infringing.
- The cycle Sales fell 15% in 2023 and were flat until 2025; an AI spending pause would empty fabs fast.
- Israel Its main fab and head office are in Israel, exposed to conflict there.
The evidence under this - 6 claims
What we still do not know
- Who the photonics customers are: Tower names none, so how concentrated that line is cannot be checked.
- How much of the contracts into 2029 is binding; the filed part runs through 2028.
- How big Tower's market is: no outside count fits what it sells.
The evidence under this - 3 claims
- The 2029 extension is management's word, partly 'contracts in advanced stages of negotiation' rather than signed (S03).
- The release warns that prepayments may have to be repaid if Tower cannot deliver the committed capacity (S02).
The figure is management's; no filing splits revenue by technology, and Tower reports one segment (S01).
Yole may count die value at a different point in the chain than Tower's wafer revenue, so the two need not be comparable (C20).
What would change our view
- Attractive→NeutralThe price rises past 80% of fair value
It needs:
- ○The share price rises to about 80% of what we think the business is worth.about ≈$139.27 today, 4% above the last close
- Attractive→UnattractiveThe price rises 20% above fair value
It needs:
- ○The share price rises to about 120% of what we think the business is worth.about ≈$215.81 today, 62% above the last close
- Attractive→NeutralThe margin slips back
It needs:
- ○Operating profit falls below 20 cents of each sales dollar in a quarter.checked at the next results, due by 10 Feb
We would also be wrong if
- Quarterly photonics sales fall below the third quarter of 2026's level during 2027.
- A top photonics customer moves a high-volume part to GlobalFoundries or TSMC.
- The trade commission or a court bars Tower's wafers in the patent cases.
What is coming
- 25 November 2026 Extraordinary general meeting on the pay policy: Whether shareholders approve the amended compensation policy for directors and officers.
Every dated event ahead
- 25 November 2026 Extraordinary general meeting on the pay policy: Whether shareholders approve the amended compensation policy for directors and officers.
- 10 February 2027 Fourth-quarter 2026 results: Whether revenue reaches the $600M guide at about a 28% operating margin, and the first-quarter 2027 guide.
- 1 April 2027 Full ownership of Fab 7 in Japan: Whether the restructuring closes and the 300mm photonics expansion has its own fab.
- 30 September 2027 Track-1 300mm production starts: Whether photonics capacity reaches about three times the third quarter of 2026, as management plans.
Since we wrote this
- 17 NovThesis writtenAttractive, medium convictionWritten after a record quarter and a 58% fall from June, to ask what the photonics ramp is worth if the margin holds.
Sources 13
Sources - 13
Every claim above cites one of these, or states the reasoning that derived it. The quote is frozen at the date it was read: a link can rot, and an agent fetch returns a reading of a page rather than the page. Backs counts the whole claim ledger, so it can name a claim this page does not surface.
- S01primarycompany filing2026-04-30the fabs and their processes, silicon photonics and SiGe platforms, named competitors, the GlobalFoundries patent suits, the Intel capacity-corridor dispute, the Japan restructuring, customer concentration and geography, tax status and Pillar Two, executives, ownership and pay, and audited statements for 2023 to 2025backsC01C02C03C04C05C06C11C15C22C23C24C25C26C32C36C38
- S02primarycompany filing2026-11-02third-quarter and nine-month revenue, margins, profit and earnings per share, the balance sheet at 30 September 2026 including customer advances, cash flow and capital spending, the fourth-quarter guidance and the chief executive's silicon photonics run-rate targetbacksC06C07C08C09C11C13C14C22C24C32C38
- S03primarytranscript2026-11-02Tower Semiconductor third-quarter 2026 earnings call transcript (FMP), held 2026-11-02data/cache/transcripts/TSEM-2026Q3.jsonsilicon photonics revenue in the quarter, the capacity plan and Track-1 timing, customer prepayments and contracts through 2029, utilization, pricing, the updated $3.6 billion target model, competition in silicon photonics, and analysts' questions
a business that contributed approximately $240 million of silicon photonics revenue in Q3 2026 alone
backsC08C09C10C11C12C16C17C39 - S04primarycompany filing2026-08-17first-half 2026 revenue, cost, operating profit and net profit against the first half of 2025backsC41
- S05primarycompany filing2026-10-13a shareholder vote on 25 November 2026 on an amended compensation policy for directors and officersbacksC26
- S06primaryindustry data2025-12-04the silicon photonic integrated circuit die market in 2024 and its 2030 forecast
was worth $404M in 2024 and is forecast to grow to more than $2.1B in 2030
backsC20 - S07primarycompany filing2026-10-14GlobalFoundries reallocating $955 million of its CHIPS Act award to silicon photonics, SiGe and advanced packaging in New York and VermontbacksC18
- S08primarycompany filing2026-08-05GlobalFoundries naming optical networking in AI data centres, through its silicon photonics and SiGe, among its strategic growth driversbacksC19
- S09primarycompany filing2026-04-30UMC describing itself as an independent foundry fabricating customers' designs at mature nodesbacksC40
- S10secondaryvendor data2026-11-16Research pack (FMP market data, FINRA short interest), as of the 16 November 2026 closecontent/TSEM/research-pack.jsoncloses, the 252-day range, the price move split into sales and multiple, analyst estimates, ratings and targets, valuation against its own six-year history, the filed-competitor cohort, the bridged company value, headcount and short interestbacksC27C28C29C30C36
- S11primarycompany filing2026-04-30revenue, gross and operating profit, research, selling and admin costs, stock pay, capital spending, cash flow and diluted shares for each year from 2020 to 2025backsC02C15C37C38
- S12primarycompany filing2026-09-12open-market sales by the chief executive and a director, each without the Rule 10b5-1 plan box tickedbacksC27
- S13primarycompany filing2026-04-16TSMC competing with other foundries and chipmakers, at the leading edge where most of its revenue sitsbacksC40